CYP2A6 and breast carcinoma: A 25% upregulation in CYP2A6 expression has been observed among ER-α-positive post-menopausal breast cancer patients, which is contradictory to a study conducted by Iscan and colleagues that failed to detect any mRNA expression of CYP2A6 in healthy or cancerous breast tissues [15].